Efficient synthesis of NK(1) receptor antagonist aprepitant using a crystallization-induced diastereoselective transformation.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American Chemical Society

• Publication date

  2003-01-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JA027458GPMID 12590540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crystallization-induced diastereoselection: asymmetric synthesis of substance P inhibitors.

  2002cited by this paper
• First stereoselective synthesis of 2-deoxy-alpha-D-ribosyl-1-phosphate: novel application of crystallization-induced asymmetric transformation.

  2002cited by this paper
• Practical asymmetric synthesis of aprepitant, a potent human NK-1 receptor antagonist, via a stereoselective Lewis acid-catalyzed trans acetalization reaction.

  2002cited by this paper
• Asymmetric strecker synthesis of alpha-amino acids via a crystallization-induced asymmetric transformation using (R)-phenylglycine amide as chiral auxiliary.

  2001cited by this paper
• A crystallization-induced stereoselective glycosidation reaction in the synthesis of the anticancer drug etoposide.

  2001cited by this paper
• Stereocontrolled asymmetric synthesis of alpha-hydroxy-beta-amino acids. A stereodivergent approach.

  2001cited by this paper
• Novel [1,2]- and [2,3]-Wittig rearrangements of alpha-benzyloxy beta-CF(3)-beta-lactam enolates.

  2001cited by this paper
• Synthesis of enantioenriched axially chiral anilides from atropisomerically enriched tartarate ortho-anilides.

  2001cited by this paper
• Clathration-induced asymmetric transformation of cefadroxil.

  2000cited by this paper
• Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.

  1999cited by this paper
• Recent advances in neurokinin receptor antagonists.

  1999cited by this paper
• Discovery of novel pyridinopolyamines with potent antimicrobial activity: deconvolution of mixtures synthesized by solution-phase combinatorial chemistry.

  1998cited by this paper
• Distinct mechanism for antidepressant activity by blockade of central substance P receptors.

  1998cited by this paper
• Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist.

  1998cited by this paper
• Anomeric-oxygen activation for glycoside synthesis: the trichloroacetimidate method.

  1994cited by this paper
• Neurotransmitter functions of mammalian tachykinins.

  1993cited by this paper
• Tachykinin receptors and tachykinin receptor antagonists.

  1993cited by this paper
• The primary structure and gene organization of human substance P and neuromedin K receptors.

  1992cited by this paper
• Molecular cloning, structural characterization and functional expression of the human substance P receptor.

  1991cited by this paper
• The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of cDNA from tracheal and gastric tissues.

  1990cited by this paper
• Histamine H2 receptor antagonists. 1. Synthesis of N-cyano and N-carbamoyl amidine derivatives and their biological activities.

  1984cited by this paper
• A novel synthesis of prostaglandin F.

  1973cited by this paper
• Model dehydrogenase reactions. Reduction of N-methylacridinium ion by reduced nicotinamide adenine dinucleotide and its derivatives.

  1973cited by this paper

• Chiral resolution of (R, S)-1-chloro-1-phenylethane by haloalkane dehalogenase DbjA in micro-aqueous phase.

  2025cites this paper
• Light-Driven Crystallization-Induced Dynamic Resolution of Amines.

  2025cites this paper
• Artificial Chiral Trinuclear Zn Catalysts: Design, Self-Assembly and Unprecedented Efficiency in Asymmetric Hydroboration of Ketones

  2025cites this paper
• A versatile cobalt catalyst for highly enantioselective hydrogenation of carbonyl compounds

  2024cites this paper
• Zinc chloride-catalyzed cyclizative 1,2-rearrangement enables facile access to morpholinones bearing aza-quaternary carbons

  2023cites this paper
• Metallaphotoredox-Mediated Decarboxylative Cross-Coupling of α-Oxy Morpholine Carboxylic Acids and (Hetero)Aryl Halides.

  2023cites this paper
• Chronic pruritus: from pathophysiology to drug design.

  2023cites this paper
• Recyclable Mn(I) Catalysts for Base‐Free Asymmetric Hydrogenation: Mechanistic, DFT and Catalytic Studies

  2022cites this paper
• The Catalysis Laboratory at Merck: 20 Years of Catalyzing Innovation

  2022cites this paper
• Testing the role of the backbone length using bidentate and tridentate ligands in manganese-catalyzed asymmetric hydrogenation

  2022cites this paper
• The crystal structure of the S154Y mutant carbonyl reductase from Leifsonia xyli explains enhanced activity for 3,5-Bis(trifluoromethyl)acetophenone reduction.

  2022cites this paper
• Biocatalysis in Flow for Drug Discovery

  2021cites this paper
• Effective asymmetric preparation of (R)-1-[3-(trifluoromethyl)phenyl]ethanol with recombinant E. coli whole cells in an aqueous Tween-20/natural deep eutectic solvent solution

  2021cites this paper
• Green Chemistry in the Synthesis of Pharmaceuticals.

  2021cites this paper
• Aprepitant is a novel, selective activator of the K2P channel TRAAK.

  2021cites this paper
• Copper-Catalyzed Asymmetric Reductions of Aryl/Heteroaryl Ketones under Mild Aqueous Micellar Conditions.

  2021cites this paper
• Industrial Applications of Asymmetric (Transfer) Hydrogenation

  2021cites this paper
• Characterization of Yeast Strains with Ketoreductase Activity for Bioreduction of Ketones

  2021cites this paper
• Mn(i) phosphine-amino-phosphinites: a highly modular class of pincer complexes for enantioselective transfer hydrogenation of aryl-alkyl ketones

  2021cites this paper
• Identification of a newly isolated Rhodotorula mucilaginosa NQ1 and its development for the synthesis of bulky carbonyl compounds by whole‐cell bioreduction

  2020cites this paper
• Ketone Reductase Biocatalysis in the Synthesis of Chiral Intermediates Toward Generic Active Pharmaceutical Ingredients

  2020cites this paper
• Amidase as a versatile tool in amide-bond cleavage: From molecular features to biotechnological applications.

  2020cites this paper
• Structure-based mechanisms: On the way to apply alcohol dehydrogenases/reductases to organic-aqueous systems.

  2020cites this paper
• Synthesis of Enantioenriched β-Hydroxy-γ-Acetal Enamides by Rhodium-Catalyzed Asymmetric Transfer Hydrogenation.

  2020cites this paper
• An iron variant of the Noyori hydrogenation catalyst for the asymmetric transfer hydrogenation of ketones.

  2020cites this paper
• Continuous production of aprepitant chiral intermediate by immobilized amidase in a packed bed bioreactor.

  2019cites this paper
• Retracted: The Manganese(I)‐Catalyzed Asymmetric Transfer Hydrogenation of Ketones: Disclosing the Macrocylic Privilege

  2019cites this paper
• The Manganese(I)-Catalyzed Asymmetric Transfer Hydrogenation of Ketones: Disclosing the Macrocyclic Privilege.

  2019cites this paper
• Application of Organometallic Catalysts in API Synthesis

  2019cites this paper
• High throughput analysis enables high throughput experimentation in pharmaceutical process research

  2019cites this paper
• Three-Dimensional NMR Spectroscopy of Fluorinated Pharmaceutical Solids under Ultrafast Magic Angle Spinning.

  2019cites this paper
• Catalytic Homogeneous Asymmetric Hydrogenation: Successes and Opportunities

  2019cites this paper
• Preparation of chiral 3-oxocycloalkanecarbonitrile and its derivatives by crystallization-induced diastereomer transformation of ketals with chiral 1,2-diphenylethane-1,2-diol

  2018cites this paper
• A Catalyst from Burkholderia cenocepacia for Efficient Anti-Prelog’s Bioreduction of 3,5-Bis(Trifluoromethyl) Acetophenone

  2018cites this paper
• A Straightforward Deracemization of sec -Alcohols Combining Organocatalytic Oxidation and Biocatalytic Reduction

  2018cites this paper
• Developing Next Generation Tools for Computational Toxicology

  2018cites this paper
• Pot Economy Synthesis

  2018cites this paper
• Hydrogenation, Hydroformylation, and Other Reductions

  2018cites this paper
• Efficient chemoenzymatic synthesis of (S)-α-amino-4-fluorobenzeneacetic acid using immobilized penicillin amidase.

  2018cites this paper
• Asymmetric Transfer Hydrogenation of Ketones Using New Iron(II) (P‐NH‐N‐P′) Catalysts: Changing the Steric and Electronic Properties at Phosphorus P′

  2017cites this paper
• Iron Complexes with Chiral N/P Macrocycles as Catalysts for Asymmetric Transfer Hydrogenation

  2017cites this paper
• Metal–Ligand Bifunctional Catalysis: The “Accepted” Mechanism, the Issue of Concertedness, and the Function of the Ligand in Catalytic Cycles Involving Hydrogen Atoms

  2017cites this paper
• Highly diastereoselective crystallization-induced asymmetric transformation of 1,3-disubstituted-tetrahydro-β-carbolines in water

  2017cites this paper
• Highly Enantioselective Transfer Hydrogenation of Polar Double Bonds by Macrocyclic Iron(II)/(NH)2P2 Catalysts

  2016cites this paper
• Metal-Catalysed Transfer Hydrogenation of Ketones

  2016cites this paper
• Benzylamines via Iron-Catalyzed Direct Amination of Benzyl Alcohols

  2016cites this paper
• The mechanism of enantioselective ketone reduction with Noyori and Noyori-Ikariya bifunctional catalysts.

  2016cites this paper
• Iron(II)/(NH)2P2 Macrocycles: Modular, Highly Enantioselective Transfer Hydrogenation Catalysts

  2016cites this paper
• Development of an Immobilized Ketoreductase for Enzymatic (R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethanol Production

  2015cites this paper
• Efficient Synthesis of (S)-3-(4-Fluorophenyl)morpholin-2-one, a Key Chiral Intermediate of Aprepitant

  2015cites this paper
• Highly enantioselective transfer hydrogenation of ketones with chiral (NH)2 P2 macrocyclic iron(II) complexes.

  2015cites this paper
• Rational development of iron catalysts for asymmetric transfer hydrogenation.

  2014cites this paper
• Systematic approach to conformational sampling for assigning absolute configuration using vibrational circular dichroism.

  2014cites this paper
• [1,2]-Wittig rearrangement

  2014cites this paper
• Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011).

  2014cites this paper
• In vitro metabolic pathway construction in an immobilised enzyme microreactor (IEMR)

  2014cites this paper
• Asymmetric Hydrogenation of 3,5-Bistrifluoromethyl Acetophenone in Pilot Scale with Industrially Viable Ru/Diphosphine–Benzimidazole Complexes

  2014cites this paper
• Characterization of a robust anti-Prelog short-chain dehydrogenase/reductase ChKRED20 from Chryseobacterium sp. CA49

  2014cites this paper
• Bi(OTf)3 as a Dual Role Catalyst. Synthesis of Substituted Morpholine Derivatives via Catalytic O-Allylation

  2014cites this paper
• Research and Technology Directions

  2014cites this paper
• Influence of Cofactor Regeneration Strategies on Preparative-Scale, Asymmetric Carbonyl Reductions by Engineered Escherichia coli

  2014cites this paper
• Stereoselective bromofunctionalization of alkenes.

  2014cites this paper
• Synthesis of the major isomers of Aprepitant and Fosaprepitant

  2013cites this paper
• Amine(imine)diphosphine Iron Catalysts for Asymmetric Transfer Hydrogenation of Ketones and Imines

  2013cites this paper
• Rhodium-catalysed asymmetric hydrogenation as a valuable synthetic tool for the preparation of chiral drugs.

  2013cites this paper
• Biocatalytic Synthesis of Chiral Alcohols and Amino Acids for Development of Pharmaceuticals

  2013cites this paper
• Morpholines. Synthesis and biological activity

  2013cites this paper
• Green Chemistry in Drug Development

  2013cites this paper
• 9.10 Industrial Applications of Organocatalysis

  2012cites this paper
• Asymmetric homogeneous hydrogenations at scale.

  2012cites this paper
• Multicomponent approach in the synthesis of 2,2,6-trisubstituted morpholine derivatives.

  2012cites this paper
• Microscale Approaches to the Design and Optimisation of Equilibrium Controlled Bioconversions

  2012cites this paper
• Chapter 11 – Workup

  2012cites this paper
• 9.5 Industrial Application of the Asymmetric Reduction of C=O and C=N Bonds, including Enamides and Enamines

  2012cites this paper
• Corey–Itsuno Reduction of Ketones: A Development of Safe and Inexpensive Process for Synthesis of Some API Intermediates

  2012cites this paper
• Large-Scale Carbonyl Reductions in the Pharmaceutical Industry

  2012cites this paper
• New neurokinin (NK-1) receptor antagonist crystal form and preparation method thereof

  2012cites this paper
• Method for preparing 3-(4-fluorophenyl)-4-benzyl-2-molindone

  2012cites this paper
• Chemistry in the Pharmaceutical Industry

  2012cites this paper
• 一种神经激肽(nk-1)受体拮抗剂新晶型及其制备方法

  2012cites this paper
• Development of aprepitant, the first neurokinin‐1 receptor antagonist for the prevention of chemotherapy‐induced nausea and vomiting

  2011cites this paper
• Procédé de préparation de 5-[[2(r)-[1(r)-[3,5-bis(trifluorométhyl)phényl]éthoxy]-3(s)-4-fluorophényl-4-morpholinyl]méthyl]-1,2-dihydro-3h-1,2,4-triazole-3-one

  2011cites this paper
• Enantioselective access to chiral drugs by using asymmetric hydrogenation catalyzed by Rh(P-OP) complexes.

  2011cites this paper
• Industrial Application of Chiral Technologies

  2011cites this paper
• Asymmetric Bioreduction of 3,5-Bis(trifluoromethyl) Acetophenone to Its Corresponding Alcohol by Candida tropicalis

  2011cites this paper
• Asymmetric biocatalytic reduction of 3,5-bis(trifluoromethyl) acetophenone to (1R)-[3,5-bis(trifluoromethyl)phenyl] ethanol using whole cells of newly isolated Leifsonia xyli HS0904

  2011cites this paper
• Mechanistic pathways in CF3COOH-mediated deacetalization reactions.

  2010cites this paper
• Ruthenium-Catalysed Hydrogenation of Aromatic Ketones using Monodentate Phosphoramidite Ligands

  2010cites this paper
• Facile, efficient, and catalyst-free electrophilic aminoalkoxylation of olefins: scope and application.

  2010cites this paper
• Enantioselective hydrosilylation of prochiral ketones catalyzed by chiral BINAP-copper(I) complexes

  2010cites this paper
• Aprepitant (Emend): A NK1 Receptor Antagonist for the Treatment of Postchemotherapy Emesis

  2010cites this paper
• Simple and Efficient One Pot Synthetic Protocol to Construct Morpholin-2-ones.

  2010cites this paper
• Recycling of undesired isomers of key intermediate for aprepitant

  2009cites this paper
• New Targets in Migraine Therapy

  2009cites this paper
• Total production of (R)-3,5-bistrifluoromethylphenyl ethanol by asymmetric reduction of 3,5-bis(trifluoromethyl)-acetophenone in the submerged culture of Penicillium expansum isolate

  2009cites this paper
• [14C]Dimethyltitanocene and [14C]Methyl(methyltrimethylsilyl) titanocene–Reagents for the [14C]olefination of carbonyl compounds: synthesis of [14C]Aprepitant

  2009cites this paper
• Application of copper(II)-dipyridylphosphine catalyst in the asymmetric hydrosilylation of simple ketones in air.

  2009cites this paper
• Chemo-enzymatic synthesis of pharmaceutical intermediates

  2008cites this paper
• Calcitonin Gene-Related Peptide8-37 Antagonizes Capsaicin-Induced Vasodilation in the Skin: Evaluation of a Human in Vivo Pharmacodynamic Model

  2008cites this paper
• CuH-catalyzed reactions.

  2008cites this paper